EUVIMEDEUVIMED entdecken
Crossref

Expression profiles of selected circulating microRNAs (miR-192-5p and miR-155-3p) in NAFLD and their association with obesity and type 2 diabetes mellitus

Rana Mohamed, Mohamed M Sadaty, Emad El-Zayat, Sahar H Ahmed, Mohamed Awadein, Nahla O Mousa

Acta Diabetologica · 2026

DOI: 10.1007/s00592-026-02774-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Diabetologica, 2026. Verfasst von Rana Mohamed und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Technology of Medical Laboratory, Faculty of Applied Health Science Technology, Misr University for Science and Technology, P. O. Box 7…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Non-alcoholic Fatty Liver Disease, MicroRNAs, Obesity. Die Arbeit nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is a prevalent systemic metabolic disorder closely linked to obesity and type 2 diabetes mellitus (T2DM). Circulating microRNAs have emerged as potential biomarkers reflecting disease progression and metabolic risk. OBJECTIVES: This study aimed to investigate the clinical, biochemical, and molecular profiles of NAFLD patients, focusing on miRNA-155-3p and miRNA-192-5p, and to evaluate their diagnostic and predictive value. METHODS: A total of 200 participants were enrolled: 50 healthy controls, 50 NAFLD, 50 NAFLD with obesity, and 50 NAFLD with T2DM. Clinical, biochemical (liver enzymes, lipid profile, HOMA-IR, CRP, 25(OH) vitamin D) and circulating miRNA levels were measured. Statistical analyses included Kruskal-Wallis tests, ROC curves, and univariate and multivariate multinomial logistic regression. RESULTS: NAFLD patients, particularly with obesity and T2DM, showed elevated BMI, SGPT/SGOT, cholesterol, TG, LDL, HOMA-IR, and CRP (p < 0.001), and reduced vitamin D (p < 0.001). miRNA-155-3p and miRNA-192-5p were significantly upregulated (Kruskal-Wallis, p < 0.001). ROC analysis showed: miRNA-155-3p, AUC = 0.763, specificity 100% at 11.68; miRNA-192-5p, AUC = 0.727, sensitivity 83% at 1.057. Multivariate regression confirmed both miRNAs as independent risk predictors (miRNA-155-3p OR = 1.147-1.151, p = 0.023-0.027; miRNA-192-5p OR = 1.639-1.774, p = 0.001-0.006), while adjustment for HOMA-IR attenuated associations. CONCLUSIONS: Circulating miRNA-155-3p and miRNA-192-5p are potential molecular markers and risk predictors for NAFLD, linking metabolic dysregulation with hepatic pathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Non-alcoholic Fatty Liver DiseaseMicroRNAsObesityCirculating MicroRNAHumansMaleFemaleMiddle AgedAdultBiomarkersCase-Control Studies

Stichwörter der Autor:innen

InflammationInsulin resistanceMicroRNANAFLDNASHObesityType 2 diabetes mellitus (T2DM)Vitamin DmiR-155-5pmiR-192-5p

Substanzen

MicroRNAsMIRN155 microRNA, humanMIRN192 microRNA, humanBiomarkersCirculating MicroRNA

Autor:innen und Institutionen

  • Department of Technology of Medical Laboratory, Faculty of Applied Health Science Technology, Misr University for Science and Technology, P. O. Box 77, Giza, Egypt. rana.elsaied@must.edu.eg.
  • Department of Technology of Medical Laboratory, Faculty of Applied Health Science Technology, Misr University for Science and Technology, P. O. Box 77, Giza, Egypt.
  • Molecular Physiology and Biotechnology, Department of Biotechnology, Faculty of Science, Cairo University, Giza, 12613, Egypt.
  • Department of Internal Medicine, Faculty of Medicine, Misr University for Science and Technology, P. O. Box 77, Giza, Egypt.

Zitieren

APA

Mohamed, R., Sadaty, M. M., El-Zayat, E., Ahmed, S. H., Awadein, M., & Mousa, N. O. (2026). Expression profiles of selected circulating microRNAs (miR-192-5p and miR-155-3p) in NAFLD and their association with obesity and type 2 diabetes mellitus. Acta Diabetologica. https://doi.org/10.1007/s00592-026-02774-6

Vancouver

Mohamed R, Sadaty MM, El-Zayat E, Ahmed SH, Awadein M, Mousa NO. Expression profiles of selected circulating microRNAs (miR-192-5p and miR-155-3p) in NAFLD and their association with obesity and type 2 diabetes mellitus. Acta Diabetologica. 2026. doi:10.1007/s00592-026-02774-6

BibTeX
@article{Mohamed2026,
  author = {Mohamed, Rana and Sadaty, Mohamed M and El-Zayat, Emad and Ahmed, Sahar H and Awadein, Mohamed and Mousa, Nahla O},
  title = {Expression profiles of selected circulating microRNAs (miR-192-5p and miR-155-3p) in NAFLD and their association with obesity and type 2 diabetes mellitus},
  journal = {Acta Diabetologica},
  year = {2026},
  doi = {10.1007/s00592-026-02774-6}
}
Kostenlos starten →